Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Winston Pharmaceuticals Inc.

Headquarters: Vernon Hills, IL, United States of America
Year Founded: 1997
Status: Public
Industry Sector: N/A
CEO: N/A
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: N/A
Exchange/Ticker 1: Pink:WPHM
Exchange/Ticker 2: N/A
Latest Market Cap: $100

BioCentury | Dec 6, 2010
Clinical News

Dolorac Nasal Solution: Phase II data

BioCentury | Nov 23, 2010
Clinical News

Winston's nasal spray meets migraine endpoint

BioCentury | Jul 12, 2010
Clinical News

Civamide cream 0 regulatory update

BioCentury | Jul 12, 2010
Finance

Regulatory Milestones

Highlights of weekly biotech stock moves
BioCentury | Jul 7, 2010
Company News

Winston submits Civanex NDA

BioCentury | Jul 5, 2010
Finance

2H10 milestones

BioCentury | Nov 23, 2009
Clinical News

Civamide Patch: Preliminary Phase II data

BioCentury | Nov 2, 2009
Clinical News

Civamide cream 0 regulatory update

BioCentury | Aug 24, 2009
Company News

Winston Pharma management update

BioCentury | Aug 3, 2009
Company News

Winston Pharma management update

Items per page:
1 - 10 of 12
Help Center
Username
Request a Demo
Request Training
Ask a Question